Taussig Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Taussig Cancer Center brings 14 presentations to ASH 2026 in New Orleans. Its research spans bone marrow failure, inherited blood cancer risk and bispecific antibodies in myeloma. It covers germline testing in a large real-world cohort and how doses of BCMA-directed bispecifics are lowered in practice.
| Organization | ASH 2026 Attendance |
|---|---|
Taussig Cancer Center Cleveland, OH | |
Cancer center within Cleveland Clinic providing cancer care and conducting clinical research. | Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 12:00pm–1:30pm Oral Sun Dec 13 12:00pm–1:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Taussig Cancer Center
Tell us what you sell and we’ll find the people at Taussig Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction